Atea Pharmaceuticals - Stock Price History | AVIR

Historical daily share price chart and data for Atea Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Atea Pharmaceuticals as of September 27, 2021 is 33.76.
  • The all-time high Atea Pharmaceuticals stock closing price was 88.44 on February 08, 2021.
  • The Atea Pharmaceuticals 52-week high stock price is 94.17, which is 178.9% above the current share price.
  • The Atea Pharmaceuticals 52-week low stock price is 18.72, which is 44.5% below the current share price.
  • The average Atea Pharmaceuticals stock price for the last 52 weeks is 39.81.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Atea Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 32.2342 30.3400 41.7800 26.3600 41.7800 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.795B $0.049B
Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29